Replication status in leukocytes of treated and untreated patients with polycythemia vera and essential thrombocytosis.

The replication status of malignant cells is usually asynchronous. However, to date the pattern of replication has not been studied in myeloproliferative disorders nor has the effect of chemotherapy been systematically evaluated. Therefore, we used fluorescence in situ hybridization to interphase nuclei in PHA-stimulated peripheral blood lymphocytes to examine replication timing of three alleles associated with the malignant process. The study group comprised hydroxyurea treated and untreated patients with essential thrombocytosis (ET) or polycythemia vera (PV). A significantly higher rate of the asynchronous pattern of replication in both treated and untreated patients was found as compared to healthy controls. The highest rate of asynchronous replication was observed in untreated patients. Also, the frequency of the two doublets pattern was significantly higher in the untreated group compared to the treated patients and to the control groups. In conclusion, patients with PV and ET have a higher rate of asynchronous pattern of replication. A possible correlation between disease activity and the pattern of replication is suggested. The effect of hydroxyurea on the pattern of replication is variable.

[1]  J. Westin,et al.  A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. , 1988, Blood.

[2]  C. Schildkraut,et al.  Replication program of active and inactive multigene families in mammalian cells , 1988, Molecular and cellular biology.

[3]  P. Crossen.  Genes and chromosomes in chronic B-cell leukemia. , 1997, Cancer genetics and cytogenetics.

[4]  J. Whang‐Peng.  Report on essential thrombocythemia. , 1981, Cancer genetics and cytogenetics.

[5]  M. Lishner,et al.  Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. , 2000, Experimental hematology.

[6]  M. Lishner,et al.  Asynchronous replication of p53 and 21q22 loci in chronic lymphocytic leukemia , 1997, Human Genetics.

[7]  Holmquist Gp.  Role of replication time in the control of tissue-specific gene expression. , 1987 .

[8]  E. Wattel,et al.  Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. , 1998, Blood.

[9]  D. Ward,et al.  Delineation of DNA replication time zones by fluorescence in situ hybridization. , 1992, The EMBO journal.

[10]  R. Fisher,et al.  Leukemic transformation in polycythemia vera: Analysis of risk factors , 1990, American journal of hematology.

[11]  L. Avivi,et al.  Asynchronous replication of homologous α-satellite DNA loci in man is associated with nondisjunction , 1998, Cytogenetic and Genome Research.

[12]  M. Lishner,et al.  Temporal differences in replication timing of homologous loci in malignant cells derived from CML and lymphoma patients , 1998, Genes, chromosomes & cancer.

[13]  A. Amiel,et al.  Replication pattern of the p53 and 21q22 loci in the premalignant and malignant stages of carcinoma of the cervix , 1998, Cancer.

[14]  M. Lishner,et al.  Replication pattern in cancer: asynchronous replication in multiple myeloma and in monoclonal gammopathy. , 1999, Cancer genetics and cytogenetics.

[15]  D. J. Driscoll,et al.  Allele-specific replication timing of imprinted gene regions , 1993, Nature.

[16]  A. Green,et al.  Leukemic Transformation in Polycythemia Vera , 1998 .

[17]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[18]  T. Canfield,et al.  Association of fragile X syndrome with delayed replication of the FMR1 gene , 1993, Cell.

[19]  L. Avivi,et al.  Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma: A novel genetic alteration associated with malignancy , 2000, Genes, chromosomes & cancer.

[20]  N. Berlin.  Diagnosis and classification of the polycythemias. , 1975, Seminars in hematology.

[21]  K. Kinzler,et al.  The Genetic Basis of Human Cancer , 1997 .

[22]  G. Dewald,et al.  Chromosome studies in 104 patients with polycythemia vera. , 1991, Mayo Clinic proceedings.

[23]  R. Berger,et al.  Cytogenetic studies on acute nonlymphocytic leukemias following polycythemia vera. , 1984, Cancer genetics and cytogenetics.

[24]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[25]  D. Case.  Absence of a specific chromosomal marker in essential thrombocythemia. , 1984, Cancer genetics and cytogenetics.